These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


122 related items for PubMed ID: 9325342

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. High-efficiency expression and characterization of the synaptic-vesicle monoamine transporter from baculovirus-infected insect cells.
    Sievert MK, Thiriot DS, Edwards RH, Ruoho AE.
    Biochem J; 1998 Mar 01; 330 ( Pt 2)(Pt 2):959-66. PubMed ID: 9480916
    [Abstract] [Full Text] [Related]

  • 3. The photoactivatable inhibitor 7-azido-8-iodoketanserin labels the N terminus of the vesicular monoamine transporter from bovine chromaffin granules.
    Sagné C, Isambert MF, Vandekerckhove J, Henry JP, Gasnier B.
    Biochemistry; 1997 Mar 18; 36(11):3345-52. PubMed ID: 9116013
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Amino- and amido-tetrabenazine derivatives: synthesis and evaluation as potential ligands for the vesicular monoamine transporter.
    Canney DJ, Kung MP, Kung HF.
    Nucl Med Biol; 1995 May 18; 22(4):527-35. PubMed ID: 7550031
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. In vitro and in vivo studies of benzisoquinoline ligands for the brain synaptic vesicle monoamine transporter.
    Lee LC, Vander Borght T, Sherman PS, Frey KA, Kilbourn MR.
    J Med Chem; 1996 Jan 05; 39(1):191-6. PubMed ID: 8568807
    [Abstract] [Full Text] [Related]

  • 12. Lobeline displaces [3H]dihydrotetrabenazine binding and releases [3H]dopamine from rat striatal synaptic vesicles: comparison with d-amphetamine.
    Teng L, Crooks PA, Dwoskin LP.
    J Neurochem; 1998 Jul 05; 71(1):258-65. PubMed ID: 9648873
    [Abstract] [Full Text] [Related]

  • 13. Identification of the serotonin-S2 receptor ligand binding site by photoaffinity labelling with 7-azido-8-[125I]ketanserin ([125I]AZIK).
    Wouters W, Van Dun J, Laduron PM.
    FEBS Lett; 1987 Mar 23; 213(2):359-64. PubMed ID: 3556587
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Binding of alpha-dihydrotetrabenazine to the vesicular monoamine transporter is stereospecific.
    Kilbourn M, Lee L, Vander Borght T, Jewett D, Frey K.
    Eur J Pharmacol; 1995 May 24; 278(3):249-52. PubMed ID: 7589162
    [Abstract] [Full Text] [Related]

  • 16. Binding of [3H]dihydrotetrabenazine and [125I]azidoiodoketanserin photoaffinity labeling of the monoamine transporter of platelet 5-HT organelles.
    Cesura AM, Bertocci B, Da Prada M.
    Eur J Pharmacol; 1990 Sep 04; 186(1):95-104. PubMed ID: 2149340
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Photoaffinity-labeled ligand binding domains on dopamine transporters identified by peptide mapping.
    Vaughan RA.
    Mol Pharmacol; 1995 May 04; 47(5):956-64. PubMed ID: 7746282
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.